Medicare Enrolled
Dr. Lesley Martin, M.D.
Hematology & Oncology · Concord, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Martin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Martin
Dr. Lesley Martin is a hematology & oncology specialist in Concord, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martin performed 94,415 Medicare services across 1,968 unique beneficiaries.
Between the years covered by Open Payments, Dr. Martin received a total of $6,133 from 49 pharmaceutical and/or device companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Martin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$6,133 industry payments
Medicare Practice Summary
Medicare Utilization ↗94,415
Medicare services
Top 8% in CA for hematology & oncology
1,968
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,721 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
34,680 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
26,850 | $0 | $6 |
| Pembrolizumab injection (Keytruda) | 9,200 | $43 | $126 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,320 | $6 | $25 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,273 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,270 | $1 | $99 |
| Denosumab injection (Prolia/Xgeva) | 2,580 | $18 | $54 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,020 | $85 | $1,074 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
818 | $107 | $305 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
742 | $30 | $113 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
741 | $157 | $406 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
447 | $139 | $514 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
417 | $16 | $79 |
| Anti-nausea injection (ondansetron/Zofran) | 396 | $0 | $2 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
385 | $2 | $26 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
350 | $71 | $222 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
306 | $13 | $75 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
305 | $13 | $64 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
268 | $1 | $4 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
260 | $65 | $244 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
254 | $7 | $518 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
223 | $2 | $9 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
207 | $29 | $110 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
193 | $68 | $251 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
138 | $20 | $80 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
131 | $26 | $90 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
129 | $33 | $197 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
87 | $20 | $65 |
| New patient office visit, complex (60-74 min) | 77 | $199 | $569 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
72 | $19 | $91 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
61 | $1 | $13 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
54 | $38 | $190 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
48 | $106 | $347 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
31 | $1 | $15 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $111 | $412 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
21 | $84 | $305 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
18 | $23 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $79 | $210 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
39.1% high complexity
58.2% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,133
Total received (2018-2024)
Avg $876/year across 7 years
Top 40% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,756 (93.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$377 (6.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,026
2023
$1,176
2022
$689
2021
$246
2020
$235
2019
$1,387
2018
$1,373
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$163
Merck Sharp & Dohme LLC
$127
ABBVIE INC.
$94
E.R. Squibb & Sons, L.L.C.
$92
Celgene Corporation
$81
Novartis Pharmaceuticals Corporation
$68
Genentech USA, Inc.
$52
Incyte Corporation
$47
PFIZER INC.
$44
Agios Pharmaceuticals, Inc.
$36
Gilead Sciences, Inc.
$36
ARRAY BIOPHARMA INC
$26
Janssen Biotech, Inc.
$26
Eisai Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Deciphera Pharmaceuticals Inc.
$23
Astellas Pharma US Inc
$22
Janssen Pharmaceuticals, Inc
$22
SERVIER PHARMACEUTICALS LLC
$20
Top 3 companies account for 37.4% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$675
Novartis Pharmaceuticals Corporation
$637
Celgene Corporation
$415
AstraZeneca Pharmaceuticals LP
$316
E.R. Squibb & Sons, L.L.C.
$312
Astellas Pharma US Inc
$308
Merck Sharp & Dohme LLC
$294
Amgen Inc.
$276
Merck Sharp & Dohme Corporation
$271
Genentech USA, Inc.
$254
Pharmacyclics LLC, An AbbVie Company
$226
Takeda Pharmaceuticals U.S.A., Inc.
$223
GlaxoSmithKline, LLC.
$137
Seattle Genetics, Inc.
$117
Eisai Inc.
$111
TESARO, Inc.
$110
ABBVIE INC.
$94
Incyte Corporation
$91
Seagen Inc.
$89
Janssen Biotech, Inc.
$81
Gilead Sciences, Inc.
$81
Kite Pharma, Inc.
$76
EISAI INC.
$71
Octapharma USA, Inc.
$62
Agios Pharmaceuticals, Inc.
$57
Exelixis Inc.
$56
EMD Serono, Inc.
$55
Organon LLC
$53
JAZZ PHARMACEUTICALS INC.
$48
Bayer HealthCare Pharmaceuticals Inc.
$46
BeiGene USA, Inc.
$41
Deciphera Pharmaceuticals Inc.
$40
Acrotech Biopharma LLC
$40
Janssen Pharmaceuticals, Inc
$37
GENZYME CORPORATION
$33
Clovis Oncology, Inc.
$33
ARRAY BIOPHARMA INC
$26
AVEO Pharmaceuticals, Inc.
$25
SOBI, INC
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Foundation Medicine, Inc.
$23
Daiichi Sankyo Inc.
$20
SERVIER PHARMACEUTICALS LLC
$20
Adaptive Biotechnologies Corporation
$19
Shire North American Group Inc
$19
Sirtex Medical Inc
$18
Kyowa Kirin, Inc.
$17
Abbott Laboratories
$16
Servier Pharmaceuticals LLC
$14
Top 3 companies account for 28.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AMPLATZER Occluders · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Bavencio · CALQUENCE · Cabometyx · DARZALEX · DAURISMO · Doptelet · ELIQUIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · FOTIVDA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NINLARO · Neulasta · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONCASPAR · ONTRUZANT · OPDIVO · OPDUALAG · OXBRYTA · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Padcev · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · Revlimid · Rubraca · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SPRYCEL · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · Tecentriq · Venclexta · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XOSPATA · XTANDI · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
86
Per 100K population
7.4
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - CONCORD CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Martin is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Martin experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Martin performed 34,680 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martin receive payments from pharmaceutical companies?
Yes. Dr. Martin received a total of $6,133 from 49 companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martin's costs compare to other hematology & oncology specialists in Concord?
Dr. Martin's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Concord
Browse hematology & oncology specialists in Concord ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology